Amy Maxson felt like she was in the best shape of her life, until she couldn't catch her breath. A CT scan revealed it was ...

A cancer patient is sounding the alarm about insurance company business dealings that she said put her life and thousands of ...

Bill Arneson of Moffitt Cancer Center explains how an AI tool for medical necessity appeals cut the cost to work a claim from $50 to $5, helping his team recover $500,000 in claims that would have ...

Frederick L. Locke, MD, chair in the department of blood and marrow transplant and cellular immunotherapy at Moffitt Cancer ...

Breakthrough studies in hematopathology — including advances in genetic testing, relapse prediction and detection of hidden, disease-defining gene fusions in AML  — will be presented at the ...

The story begins in dimly lit corners of forgotten neighborhoods places where hope feels like a luxury, and survival comes ...

In an interview with Targeted Oncology, Frederick L. Locke, MD, discussed how the elimination of the REMS program for CAR T-cell therapy came about and what effects he hopes this will have on patient ...

In a battle with late-stage leukemia a local war hero found his savior thousands of miles away. “I thought I had seen the ...

Technology has been both a promise and a problem in healthcare. When EHRs arrived in hospitals, they were heralded as a revolution — bringing order to messy paper charts and standardizing how care was ...

Embargoed press materials are now available for the Association for Molecular Pathology 2025 Annual Meeting & Expo.

Starling crawled back to the overturned Jeep, pounding on locked windows and shouting for him to wake. A passing car stopped ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...